Results 151 to 160 of about 57,674 (258)

Peptidthioester und Peptidtriazolderivate durch Duale Modifikation von Peptidthiosulfonaten auf dem Harz

Angewandte Chemie, EarlyView.
Es wird eine Strategie zur dualen Modifikation von Peptiden auf der Festphase vorgestellt, die die S‐Alkinylierung von Peptidthiosulfonaten und eine regioselektive, iridiumkatalysierte Azid‐Thioalkin‐Zykloaddition umfasst. Dieses Verfahren ermöglicht zuverlässig den Zugang zu Peptiden mit komplexen, nicht‐kanonischen Modifikationen und ist mit ...
Marius Werner, Agnes Bergmann, Chenxi Liu, Mira Behnam, Christian Klein, Franziska Thomas   +5 more
wiley   +1 more source

Broad-acting antivirals: the pursuit of pan-viral therapeutics in the era of pandemics. [PDF]

J Virol
Bayurova E, Kostyushev D, Tikhonov A, Chulanov V, Gordeychuk I.   +4 more
europepmc   +1 more source

Neonatal Herpes Simplex Virus Keratitis: Bitter Lessons from a Case Report. [PDF]

Clin Case Rep
Sasan MS, Saeidinia A.
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK). [PDF]

Virus Res
Tjärnhage E, Våtsveen TK, Raki M, Nemazee D, Farhan H, Munthe L, Grodeland G.   +6 more
europepmc   +1 more source

Discovery of an Antiviral Electron Transfer Process to Create Catalytically Self‐Sufficient Viral Restriction Factors

Angewandte Chemie International Edition, EarlyView.
CYB5R3 is identified as a putative electron‐transfer partner of viperin (RSAD2), explaining why ER localisation is required for antiviral activity. Its utilisation enabled the engineering of immune‐silent, catalytically self‐sufficient antiviral restriction factor enzymes (iCAREs) that produce an antiviral nucleoside triphosphate analogue (ANTA ...
Mengdi Wu, Nghi Thao Hoang, Deborah Grifagni, Meritxell Wu‐Lu, Yujie Sheng, Theo Situmorang, Pei‐Hsin Tai, Zheng Chen, Astrid Maluta, Mohammed Hakil, Bianca Susini, Hannah Florance, Peter‐Leon Hagedoorn, John Mark Sutton, Maria‐Andrea Mroginski, Simone Ciofi‐Baffoni, Kourosh H. Ebrahimi   +16 more
wiley   +1 more source

Early-Phase Oral Antiviral Use and Post-COVID-19 Condition in Outpatients.

JAMA Netw Open
Hibino M, Shintani A, Murayama H, Morikawa N, Maeda K, Nishiguchi S, Monma E, Harada H, Takagi T, Kuroyanagi S, Endo K, Terada Y, Kinoshita M, Yoden T, Miyazawa S, Higashiue S.   +15 more
europepmc   +1 more source

Survivomics: natural product clues from virus-unaffected crops for next-generation plant immunity. [PDF]

Front Plant Sci
Pant P.
europepmc   +1 more source

Update on Treatment of Feline Infectious Peritonitis: European Advisory Board on Cat Diseases (ABCD) Guidelines. [PDF]

Viruses
Tasker S, Spiri AM, Hartmann K, Addie DD, Belák S, Bergmann M, Egberink H, Frymus T, Hofmann-Lehmann R, Marsilio F, Pennisi MG, Thiry E, Truyen U, Boucraut-Baralon C, Möstl K, Hosie MJ.   +15 more
europepmc   +1 more source

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source